CSK-1-E |
Tyrosine-protein Kinase CSK (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
9000 |
0.20 |
Binding ≤ 10μM
|
EGFR-1-E |
Epidermal Growth Factor Receptor ErbB1 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
350 |
0.26 |
Binding ≤ 10μM
|
FGFR1-1-E |
Fibroblast Growth Factor Receptor 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
43 |
0.29 |
Binding ≤ 10μM
|
FGFR2-1-E |
Fibroblast Growth Factor Receptor 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
43 |
0.29 |
Binding ≤ 10μM
|
FGFR3-1-E |
Fibroblast Growth Factor Receptor 3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
43 |
0.29 |
Binding ≤ 10μM
|
FGFR4-1-E |
Fibroblast Growth Factor Receptor 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
43 |
0.29 |
Binding ≤ 10μM
|
PGFRA-1-E |
Platelet-derived Growth Factor Receptor Alpha (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
96 |
0.28 |
Binding ≤ 10μM
|
PGFRB-1-E |
Platelet-derived Growth Factor Receptor Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7 |
0.33 |
Binding ≤ 10μM
|
SRC-1-E |
Tyrosine-protein Kinase SRC (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
9000 |
0.20 |
Binding ≤ 10μM
|
WEE1-1-E |
Serine/threonine-protein Kinase WEE1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
165 |
0.27 |
Binding ≤ 10μM
|
PGFRA-1-E |
Platelet-derived Growth Factor Receptor Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2 |
0.35 |
Functional ≤ 10μM
|
PGFRB-1-E |
Platelet-derived Growth Factor Receptor Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5 |
0.33 |
Functional ≤ 10μM
|
Z80152-1-O |
HCT-8 (Ileocecal Adenocarcinoma) (cluster #1 Of 2), Other |
Other |
420 |
0.26 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
280 |
0.26 |
Functional ≤ 10μM
|
Z80742-1-O |
C6 (Glioma Cells) (cluster #1 Of 3), Other |
Other |
5 |
0.33 |
Functional ≤ 10μM
|
Z80951-1-O |
NIH3T3 (Fibroblasts) (cluster #1 Of 4), Other |
Other |
350 |
0.26 |
Functional ≤ 10μM
|
Z81331-1-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
270 |
0.26 |
Functional ≤ 10μM
|